Literature DB >> 24620380

Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.

Pierre Berlioux, Marie Angèle Robic, Hélèe Poirson, Sophie Métivier, Philippe Otal, Carine Barret, Frédéric Lopez, Jean Marie Péron, Jean Pierre Vinel, Christophe Bureau.   

Abstract

UNLABELLED: Transjugular intrahepatic portosystemic shunts (TIPS) is a second-line treatment because of an increased incidence of overt hepatic encephalopathy (OHE). A better selection of patients to decrease this risk is needed and one promising approach could be the detection of minimal hepatic encephalopathy (MHE). The aim of the present prospective study was to determine whether pre-TIPS minimal hepatic encephalopathy was predictive of post-TIPS OHE and to compare Psychometric Hepatic Encephalopathy Sum Score(PHES) and the Critical Flicker Frequency (CFF) in this setting. From May 2008 to January 2011, 54 consecutive patients treated with TIPS were included. PHES and CFF were performed 1 to 7 days before and after TIPS at months 1, 3, 6, 9, and 12 or until liver transplantation or death. Before TIPS, MHE was detected by PHES and CFF in 33% and 39% of patients, respectively. After the TIPS procedure, 19 patients (35%) experienced a total of 64 episodes of OHE. OHE developed significantly more often inpatients for whom an indication for TIPS had been refractory ascites, with a history of OHE or of renal failure, lower hemoglobin level, or MHE as diagnosed by CFF. Post-TIPS OHE was more accurately predicted by CFF than by PHES. Absence of MHE at CFF had a good negative predictive value (91%) for the risk of post-TIPS recurrent OHE, defined as the occurrence of three or more episodes of OHE or of one episode which lasted more than 15 days. The absence of pre-TIPS history of OHE and a CFF value equal to or greater than 39 Hz had a 100% negative predictive value for post-TIPS recurrent OHE.
CONCLUSION: Aiming to decrease the rate of post-TIPS HE, the use of CFF could help selecting patients for TIPS.

Entities:  

Mesh:

Year:  2014        PMID: 24620380     DOI: 10.1002/hep.26684

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

2.  Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Silvia Nardelli; Stefania Gioia; Chiara Pasquale; Ilaria Pentassuglio; Alessio Farcomeni; Manuela Merli; Filippo Maria Salvatori; Leandra Nikolli; Sabrina Torrisi; Francesca Greco; Valeria Nicoletti; Oliviero Riggio
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

Review 3.  Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

4.  Longitudinal Monitoring of Hepatic Blood Flow before and after TIPS by Using 4D-Flow MR Imaging.

Authors:  Peter Bannas; Alejandro Roldán-Alzate; Kevin M Johnson; Michael A Woods; Orhan Ozkan; Utaroh Motosugi; Oliver Wieben; Scott B Reeder; Harald Kramer
Journal:  Radiology       Date:  2016-05-12       Impact factor: 11.105

Review 5.  The history and future of transjugular intrahepatic portosystemic shunt: food for thought.

Authors:  Wael E Saad
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

Review 6.  Qualifying and quantifying minimal hepatic encephalopathy.

Authors:  Marsha Y Morgan; Piero Amodio; Nicola A Cook; Clive D Jackson; Gerald Kircheis; Mette M Lauridsen; Sara Montagnese; Sami Schiff; Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2015-09-28       Impact factor: 3.584

7.  Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.

Authors:  Marco Senzolo; Lisa Zarantonello; Chiara Formentin; Costanza Orlando; Raffaello Beltrame; Anna Vuerich; Paolo Angeli; Patrizia Burra; Sara Montagnese
Journal:  Metab Brain Dis       Date:  2019-09-10       Impact factor: 3.584

8.  Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.

Authors:  Ahmad Khan; Sanjay Maheshwari; Kamesh Gupta; Khadija Naseem; Monica Chowdry; Shailendra Singh
Journal:  J Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 4.029

9.  Use of concomitant variceal embolization and prophylactic antiplatelet/anticoagulative in transjugular intrahepatic portosystemic shunting: A retrospective study of 182 cirrhotic portal hypertension patients.

Authors:  Yingmei Tang; Sheng Zheng; Jinhui Yang; Weimin Bao; Lihong Yang; Yingchun Li; Ying Xu; Jing Yang; Yuyun Tong; Jinhang Gao; Chengwei Tang
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 10.  North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.

Authors:  Justin R Boike; Bartley G Thornburg; Sumeet K Asrani; Michael B Fallon; Brett E Fortune; Manhal J Izzy; Elizabeth C Verna; Juan G Abraldes; Andrew S Allegretti; Jasmohan S Bajaj; Scott W Biggins; Michael D Darcy; Maryjane A Farr; Khashayar Farsad; Guadalupe Garcia-Tsao; Shelley A Hall; Caroline C Jadlowiec; Michael J Krowka; Jeanne Laberge; Edward W Lee; David C Mulligan; Mitra K Nadim; Patrick G Northup; Riad Salem; Joseph J Shatzel; Cathryn J Shaw; Douglas A Simonetto; Jonathan Susman; K Pallav Kolli; Lisa B VanWagner
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-15       Impact factor: 13.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.